SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
任一
Lv1
50 积分
2023-11-19 加入
最近求助
最近应助
互助留言
421 RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY WITH ESCALATING DOSES OF ADRULIPASE ALFA ON TOP OF A STABLE DOSE OF PORCINE PANCREATIC ENZYMES (PPE) IN CF PATIENTS NOT FULLY COMPENSATED WITH PPE AS SOLE THERAPY
8天前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
10天前
已完结
Therapeutic opportunities for the treatment of NASH with genetically validated targets
12天前
已完结
Mechanisms of pruritus in cholestasis: understanding and treating the itch
16天前
已完结
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
19天前
已完结
421 RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY WITH ESCALATING DOSES OF ADRULIPASE ALFA ON TOP OF A STABLE DOSE OF PORCINE PANCREATIC ENZYMES (PPE) IN CF PATIENTS NOT FULLY COMPENSATED WITH PPE AS SOLE THERAPY
21天前
已关闭
Evaluating pruritus and fatigue in patients with treatment-refractory primary biliary cholangitis
24天前
已完结
Scleroderma epidemiology update
29天前
已完结
Challenges and opportunities in NASH drug development
1个月前
已完结
Preclinical characterization of HPG7233, a potent, liver-target and highly selective thyroid hormone receptor beta agonist for non-alcoholic steatohepatitis
1个月前
已完结
没有进行任何应助
感谢
10天前
其他途径已有【积分已退回】
20天前
感谢
24天前
感谢
29天前
感谢
1个月前
感谢
1个月前
感谢
1个月前
doi错误
3个月前
感谢
4个月前
感谢
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论